NULASTIN, Inc. – Trademark Portfolio
Entity Type: 03
NULASTIN, Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 15 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 10 trademarks are registered and 1 is pending. Notable registered marks include NULASTIN, NUPROTECT, REGENATEZ, ELASTAPLEX, and FORTICELLE. The owner is based in Boulder, CO.
PO Box 7557
Boulder, CO 80306
Showing of trademarks Trademarks
Trademark Classifications
NULASTIN, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does NULASTIN, Inc. have?
NULASTIN, Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 pending, 6 abandoned.
What trademark classes does NULASTIN, Inc. file in?
NULASTIN, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are NULASTIN, Inc.'s most well-known trademarks?
NULASTIN, Inc.'s registered trademark portfolio includes well-known marks such as NULASTIN, NUPROTECT, REGENATEZ, ELASTAPLEX, and FORTICELLE. These are among 10 currently registered trademarks in the portfolio.
What is NULASTIN, Inc.'s trademark registration success rate?
NULASTIN, Inc. has a 63% trademark registration rate, with 10 out of 16 resolved applications resulting in successful registration. Currently, 1 application is pending review.